Sermorelin studies
20 journal papers mention Sermorelin in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.
Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether Sermorelin is safe, effective or approved for any use.
- Papers
- 20
- 15 articles, 5 reviews
- Earliest paper
- 1997
- Most papers in 2026 (4)
- Open access
- 45%
- free to read somewhere
- Reviews
- 25%
- of all papers listed
What kind of studies
Of 25 papers in PubMed that mention Sermorelin in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.
- Randomized controlled trials0
- Other clinical trials0
- Meta-analyses and systematic reviews0
- Other reviews7
- Case reports1
- Animal studies only0
- Studies in humans18
Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).
Registered clinical studies
Studies on ClinicalTrials.gov that mention Sermorelin in their intervention details. A registration says a study is planned or running, not what it found.
- Registered
- 27
- Completed
- 21
- Ongoing or planned
- 1
- Phase 1
- 5
- Phase 2
- 7
- Phase 3
- 4
- Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
NCT06554717RecruitingPhase 2started 2025-07-10
- Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
NCT03375788CompletedPhase 2started 2019-01-17
- Adult Growth Hormone Deficiency and Cardiovascular Risk
NCT00720902TerminatedPhase 4started 2007-02
- TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
NCT00608023CompletedPhase 3started 2007-08
- Tesamorelin Effects on Liver Fat and Histology in HIV
NCT02196831Completedstarted 2015-07-01
The five most recently updated studies. See all 27 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.
Papers per year
1997 to 2026, peak 4 papers in a year. The latest year may still be incomplete.
Where it is published
- Inpharma Weekly5 papers
- The Journal of Sexual Medicine2 papers
- Advanced Drug Delivery Reviews1 papers
- BioDrugs1 papers
- The Journal of Clinical Endocrinology & Metabolism1 papers
The papers
Most citedName in the title
- A potentially effective drug for patients with recurrent glioma: sermorelin
Yuanhao Chang, Ruoyu Huang, You Zhai et al. · Annals of Translational Medicine · 2021
Open access · CC BY-NC-ND7 citationsRead the open copy →
LatestName in title or abstract
- Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report
Sui-Ling Perez, Lynette Martinez, Michael Rosselli et al. · Frontiers in Surgery · 2026
Case reportOpen access · CC BYRead the open copy →
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz et al. · Frontiers in Endocrinology · 2026
ReviewOpen access · CC BY1 citationsRead the open copy →
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Omar F. Rahman, Steven J. Lee, William A. Seeds · JAAOS Global Research and Reviews · 2026
ReviewOpen access · CC BY-NC-ND5 citationsRead the open copy →
- (197) Peptides in Practice: Evaluating Efficacy and Safety in Men’s Health
R Arora, Arjun K. Venkatesh, Gene Austin Krishingner et al. · The Journal of Sexual Medicine · 2025
Open accessRead the open copy →
- (349) Therapeutic Peptides in Sexual Medicine: A Narrative Review
E Burchfiel, N Mills, G Saffati et al. · The Journal of Sexual Medicine · 2025
ReviewOpen accessRead the open copy →
- A potentially effective drug for patients with recurrent glioma: sermorelin
Yuanhao Chang, Ruoyu Huang, You Zhai et al. · Annals of Translational Medicine · 2021
Open access · CC BY-NC-ND7 citationsRead the open copy →
- Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males
Deepankar K. Sinha, Adithya Balasubramanian, Alexander J. Tatem et al. · Translational Andrology and Urology · 2020
ReviewOpen access · CC BY-NC-ND11 citationsRead the open copy →
- Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels
John Tucker Sigalos, Alexander W. Pastuszak, Andrew Allison et al. · American Journal of Men s Health · 2017
Study in humansOpen access · CC BY-NC3 citationsRead the open copy →
- MP76-09 GROWTH HORMONE RELEASING PEPTIDE TREATMENT IN MEN INCREASES SERUM INSULIN-LIKE GROWTH FACTOR-1 LEVELS
John Tucker Sigalos, Andrew Allison, Alexander W. Pastuszak et al. · The Journal of Urology · 2016
Open accessRead the open copy →
Each list shows up to 40 papers.See all 20 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.